Current reports
6-K
Report of Foreign Private Issuer
28 Jun 24
6-K
Moolec Science Presents Third Quarter Fiscal Year 2024 Business Update
31 May 24
6-K
Moolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference Call
24 May 24
6-K
Moolec Announces New Patent Granting in the United States For Molecular Farming Platform
30 Apr 24
6-K
Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins
23 Apr 24
6-K
Report of Foreign Private Issuer
18 Apr 24
6-K
Report of Foreign Private Issuer
12 Mar 24
6-K
Report of Foreign Private Issuer
26 Feb 24
6-K
Report of Foreign Private Issuer
22 Jan 24
6-K
Moolec Science to Host Fiscal Year 2023 Business Update Conference Call
18 Oct 23
Registration and prospectus
424B3
Prospectus supplement
2 Jul 24
424B3
Prospectus supplement
2 Jul 24
424B3
Prospectus supplement
29 Apr 24
424B3
Prospectus supplement
29 Apr 24
424B3
Prospectus supplement
15 Feb 24
424B3
Prospectus supplement
15 Feb 24
424B3
Prospectus supplement
16 Jan 24
424B3
Prospectus supplement
16 Jan 24
POS AM
Prospectus update (post-effective amendment)
15 Nov 23
POS AM
Prospectus update (post-effective amendment)
13 Nov 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
17 Nov 23
EFFECT
Notice of effectiveness
17 Nov 23
EFFECT
Notice of effectiveness
10 May 23
EFFECT
Notice of effectiveness
9 May 23
CORRESP
Correspondence with SEC
5 May 23
CORRESP
Correspondence with SEC
4 May 23
CORRESP
Correspondence with SEC
4 May 23
EFFECT
Notice of effectiveness
4 Apr 23
EFFECT
Notice of effectiveness
28 Mar 23
CORRESP
Correspondence with SEC
23 Mar 23